Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AIM ImmunoTech Inc. (AIM)
Price—Loading quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88,000 | $170,000 | $202,000 | $141,000 | $135,000 | $163,000 | $140,000 | $367,000 | $437,000 | $92,000 | $133,000 | $197,000 | $150,000 | $213,000 | $161,000 | $135,000 | $111,000 |
| Gross profit | −$40,000 | $139,000 | $160,000 | $141,000 | — | — | — | — | — | — | — | −$1.1M | −$1.1M | −$1.8M | −$882,000 | −$1.2M | −$473,000 |
| Gross margin | −45.45% | 81.76% | 79.21% | 100.00% | — | — | — | — | — | — | — | −535.03% | −722.67% | −833.80% | −547.83% | −893.33% | −426.13% |
| Research & development | $3.9M | $6.2M | $10.9M | $7.0M | $7.7M | $5.7M | $4.7M | $4.8M | $4.1M | $5.1M | $8.0M | $9.0M | $8.4M | $9.5M | $6.7M | $7.6M | $7.0M |
| Operating expenses | $11.8M | $19.9M | $32.1M | $20.1M | $19.0M | $15.3M | $12.6M | $11.9M | $11.9M | $13.9M | $16.8M | $19.3M | $17.3M | $20.6M | $14.5M | $16.5M | $13.4M |
| Operating income | −$11.7M | −$19.8M | −$31.9M | −$19.9M | −$18.8M | −$15.2M | −$12.4M | −$11.5M | −$11.4M | −$13.8M | −$16.6M | −$19.1M | −$17.2M | −$20.3M | −$14.3M | −$16.4M | −$13.3M |
| Operating margin | −13,254.55% | −11,630.59% | −15,800.00% | −14,129.79% | −13,954.07% | −9,295.71% | −8,887.86% | −3,132.43% | −2,612.36% | −15,004.35% | −12,518.80% | −9,694.92% | −11,444.67% | −9,549.30% | −8,878.88% | −12,138.52% | −11,949.55% |
| EBITDA | −$11.5M | −$19.5M | −$31.7M | −$19.7M | −$18.1M | −$14.4M | −$11.7M | −$10.6M | −$10.4M | −$12.6M | −$15.7M | −$18.4M | −$16.3M | −$19.7M | −$13.8M | −$16.0M | −$12.9M |
| EBITDA margin | −13,015.91% | −11,485.88% | −15,682.18% | −13,948.23% | −13,380.00% | −8,846.01% | −8,322.14% | −2,893.19% | −2,382.61% | −13,733.70% | −11,785.71% | −9,341.62% | −10,866.67% | −9,247.42% | −8,590.06% | −11,837.04% | −11,626.13% |
| Net income | −$14.0M | −$17.3M | −$29.0M | −$19.4M | −$19.1M | −$14.4M | −$9.4M | −$9.8M | −$8.3M | −$7.5M | −$15.2M | −$17.4M | −$16.2M | −$17.4M | −$9.0M | −$13.1M | −$7.2M |
| Net profit margin | −15,861.36% | −10,188.24% | −14,337.62% | −13,790.78% | −14,168.15% | −8,834.36% | −6,717.14% | −2,677.66% | −1,889.93% | −8,154.35% | −11,451.13% | −8,857.87% | −10,816.67% | −8,147.42% | −5,599.38% | −9,730.37% | −6,468.47% |
| Basic EPSper basic share | -$8.62 | -$30.92 | -$60.00 | -$40.00 | -$40.00 | -$45.00 | -$258.00 | -$977.00 | -$1,276.00 | -$1,496.00 | -$3,388.00 | -$4,884.00 | -$5,280.00 | -$6,336.00 | -$3,696.00 | -$5,280.00 | -$3,696.00 |
| Diluted EPSper diluted share | -$8.62 | -$30.92 | -$60.00 | -$40.00 | -$40.00 | -$45.00 | -$258.00 | -$977.00 | -$1,276.00 | -$1,496.00 | -$3,388.00 | -$4,884.00 | -$5,280.00 | -$6,336.00 | -$3,696.00 | -$5,280.00 | -$3,696.00 |
Owners
Reported shareholders
2.79%of listed shares
JANE STREET GROUP, LLC807.89K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
JANE STREET GROUP, LLC | 2.79%807.89K shares |
MITCHELL WILLIAM M | ≈1.80%522.1K shares |
Rodino Peter W III | ≈1.39%401.76K shares |
APPELROUTH STEWART | ≈1.34%388.73K shares |
BRYAN NANCY | ≈1.01%291.88K shares |
Virtu Financial LLC | 0.43%124.27K shares |
Equels Thomas K | ≈0.22%63.92K shares |
MORGAN STANLEY | 0.18%50.86K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.16%46K shares |
KELLNER TED D | ≈0.13%37.21K shares |
GOLDMAN SACHS GROUP INC | 0.11%32.44K shares |
UBS Group AG | 0.10%28.93K shares |
CHEMEROW DAVID I. | ≈0.10%28.44K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.08%21.86K shares |
VANGUARD FIDUCIARY TRUST CO | 0.06%17.52K shares |
Ground Swell Capital, LLC | 0.04%12.22K shares |
Tower Research Capital LLC (TRC) | 0.02%4.67K shares |
Continuum Advisory, LLC | <0.01%500 shares |
Community Bank, N.A. | <0.01%132 shares |
HARBOUR INVESTMENTS, INC. | <0.01%32 shares |
Percentages use 28.99M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 13, 2025Form 4 | Equels Thomas KCEO & President | BuyCommon Stock | 107 | $7.70 | $823.90 | 38.9K |
| Jun 12, 2025Form 4 | Equels Thomas KCEO & President | BuyCommon Stock | 103 | $8.70 | $896.10 | 38.7K |
| Apr 11, 2025Form 4 | MITCHELL WILLIAM MDirector | BuyCommon Stock | 196.9K | $0.03 | $5.9K | 521.7K |
| Apr 11, 2025Form 4 | Equels Thomas KCEO & President | BuyCommon Stock | 1.97M | $0.03 | $59.1K | 3.87M |
| Apr 11, 2025Form 4 | KELLNER TED DDirector | BuyCommon Stock | 1.97M | $0.03 | $59.1K | 1.97M |